Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
29.83
-0.26 (-0.86%)
May 18, 2026, 4:00 PM EDT - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $1.73 billion as of May 19, 2026. Its market cap has decreased by -0.75% in one year.
Market Cap
1.73B
Enterprise Value
1.25B
1-Year Change
-0.75%
Ranking
Category
Stock Price
$29.83
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.73B, an increase of 274.58%. That is a compound annual growth rate of 25.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.73B | -19.87% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sionna Therapeutics | 1.82B |
| Syndax Pharmaceuticals | 1.79B |
| Oculis Holding AG | 1.79B |
| Lakefront Biotherapeutics NV | 1.79B |
| Rapport Therapeutics | 1.77B |
| Zymeworks | 1.75B |
| Viridian Therapeutics | 1.73B |
| Taysha Gene Therapies | 1.71B |